Evidence mapPaperPMID 41568727Full record

ArticleJournal of extracellular vesicles2026

Oral Delivery of R-spondin1-Loaded Small Extracellular Vesicles Activates WNT Signalling Pathway to Accelerate Intestinal Injury Repair and Reverse Ageing.

Lingyan Yang, Xu Wang, Xiyang Wei, Pei Yu, Yue Liu, Shixiang Wang, Yuefang Lin, Yue Yang, Ting Jiang, Zhiping Qiao and 4 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lingyan YangGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Xu WangGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Xiyang WeiGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Pei YuGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Yue LiuZhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Shixiang WangZhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Yuefang LinGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Yue YangState Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, China.
Ting JiangGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Zhiping QiaoZhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
Jiaxiang ZhangGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Shicheng YuGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Ye-Guang ChenGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.
Yun-Shen ChanGuangzhou National Laboratory, Guangzhou, Guangdong Province, China.

Funding

Guangzhou National Laboratory Fund GZNL2025C02009National Natural Science Foundation of China 32200637National Natural Science Foundation of China 32588201National Natural Science Foundation of China 82370053
6 · The paper itself

Abstract

The intestine plays a crucial role in regulating metabolism and immunity, with functional decline occurring during injury and ageing. Stimulating the neogenesis of intestinal stem cells (ISCs) by activating the WNT/β-catenin signalling pathway represents a promising approach for intestinal tissue regeneration and injury repair. However, effective oral delivery of functional WNT signalling agonists to the gut remains challenging. Herein, we report a potent WNT/β-catenin signalling-inducing small extracellular vesicles (sEV) that can be administered orally and present remarkable therapeutic efficacy. We demonstrate that active R-spondin1 (RSPO1) protein can be loaded onto the surface of sEV via heparan sulfate proteoglycans. Notably, sEV-delivered RSPO1 (evRSPO1) effectively induces WNT/β-catenin signalling-inducing activity, enhances ISCs proliferation, and supports intestinal organoid growth in vitro. Importantly, oral administration of evRSPO1 activates the WNT/β-catenin signalling pathway in the cryptic stem cell niche, thereby accelerating tissue repair and regeneration in a radiation-induced intestinal injury model. Furthermore, evRSPO1 treatment induces ISCs proliferation and reverses the intestinal senescence phenotype in aged mice. Collectively, this study establishes evRSPO1 as a potential first-in-class, orally deliverable therapeutic that overcomes biological barriers to activate ISCs, enabling efficient intestinal tissue repair and rejuvenation.

Indexed as

AgingExtracellular VesiclesIntestinesThrombospondinsWnt Signaling PathwayAdministration, OralAnimalsbeta CateninCell ProliferationHumansIntestinal MucosaMiceMice, Inbred C57BLRegenerationR-SpondinsStem Cellsbeta CateninRSPO1 protein, mouseR-SpondinsThrombospondinsageing reversalextracellular vesiclesintestinal regenerationR‐spondin1WNT signalling

Identifiers

PMID41568727
PMCPMC12825024

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.